Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploration of Neuroprotective Properties of a Naturally Inspired Multifunctional Molecule (F24) against Oxidative Stress and Amyloid β Induced Neurotoxicity in Alzheimer’s Disease Models
Yash Pal Singh, Navneet Kumar, Khushbu Priya, et al.
ACS Chemical Neuroscience (2021) Vol. 13, Iss. 1, pp. 27-42
Closed Access | Times Cited: 21

Showing 21 citing articles:

Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer’s Disease Therapy
Akash Verma, Digambar Kumar Waiker, Neha Singh, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 745-771
Closed Access | Times Cited: 8
Design, Synthesis, and Biological Evaluation of Piperazine and N-Benzylpiperidine Hybrids of 5-Phenyl-1,3,4-oxadiazol-2-thiol as Potential Multitargeted Ligands for Alzheimer’s Disease Therapy
Digambar Kumar Waiker, Akash Verma, Akhilesh Akhilesh, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2217-2242
Closed Access | Times Cited: 19
Design and development of benzyl piperazine linked 5-phenyl-1,2,4-triazole-3-thione conjugates as potential agents to combat Alzheimer’s disease
Pidugu Venkata Ravi Kiran, Digambar Kumar Waiker, Akash Verma, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106749-106749
Closed Access | Times Cited: 16
Design, Synthesis, and Biological Evaluation of Ferulic Acid Template-Based Novel Multifunctional Ligands Targeting NLRP3 Inflammasome for the Management of Alzheimer’s Disease
Gourav Singh, Gauri Shankar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1388-1414
Closed Access | Times Cited: 5
Carbamate as a potential anti‐Alzheimer's pharmacophore: A review
Yash Pal Singh, Navneet Kumar, Brijesh Singh Chauhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1624-1651
Closed Access | Times Cited: 13
Advances of metallodrug-amyloid β aggregation inhibitors for therapeutic intervention in neurodegenerative diseases: Evaluation of their mechanistic insights and neurotoxicity
Huzaifa Yasir Khan, Azeem Ahmad, Md Nadir Hassan, et al.
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215580-215580
Closed Access | Times Cited: 13
Molecular Targets of Valeric Acid: A Bioactive Natural Product for Endocrine, Metabolic, and Immunological Disorders
Bindu Kumari, Usha Kumari, D. K. Singh, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 13, pp. 1506-1517
Closed Access | Times Cited: 3
A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 3
Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease
Gourav Singh, Sunil Kumar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2756-2778
Closed Access | Times Cited: 3
Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 4
Closed Access | Times Cited: 3
Tryptamine: A privileged scaffold for the management of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1578-1594
Closed Access | Times Cited: 9
Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy
Digambar Kumar Waiker, Akash Verma, T A Gajendra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116409-116409
Closed Access | Times Cited: 2
Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment
Akash Verma, Digambar Kumar Waiker, Neha Singh, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116450-116450
Closed Access | Times Cited: 2
Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease
Harish Kumar, Anju Goyal, Navneet Kumar, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 11, pp. 1931-1947
Closed Access | Times Cited: 9
Berberine derivatives as inhibitors of acetylcholinesterase: A systematic review
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 6, pp. 1592-1603
Closed Access | Times Cited: 4
Repurposing the in-house generated Alzheimer’s disease targeting molecules through computational and preliminary in-vitro studies for the management of SARS-coronavirus-2
Gourav Singh, Jobin Thomas, Sahil Wadhawa, et al.
Molecular Diversity (2023) Vol. 28, Iss. 5, pp. 2847-2862
Closed Access | Times Cited: 2
Design, synthesis and biological evaluation of novel piperic acid and benzylpiperazine hybrid molecules for improvement of memory impairment via cholinesterase inhibitory activity
Jitendra Kumar, Gauri Shankar, Sunil Kumar, et al.
Chemical Papers (2024) Vol. 79, Iss. 1, pp. 395-415
Closed Access
Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer’s disease
Gauri Shankar, Prabhat Kumar, Sanskriti Rai, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117066-117066
Closed Access
Phytochemistry and pharmacological advances of Ascophyllum nodosum in the management of human diseases: A comprehensive review
Brijesh Singh Chauhan, Yash Pal Singh
Phytomedicine Plus (2024), pp. 100718-100718
Open Access
Deoxyvasicinone hybrids in the management of Alzheimer's disease: Recent advances on manmade derivatives, pharmacological activities, and structure–activity relationship
A Gaur, Yash Pal Singh, Rajiv Sharma, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Vitamin-Based Derivatives for the Management of Alzheimer’s Disease
Tanmaykumar Varma, Pradnya Kamble, Madhavi Kumari, et al.
(2023), pp. 317-344
Closed Access
Page 1

Scroll to top